SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kazutaka Masuko, Daiko Wakita, Yuji Togashi, Toshiyuki Kita, Hidemitsu Kitamura, Takashi Nishimura, Artificially synthesized helper/killer-hybrid epitope long peptide (H/K-HELP): Preparation and immunological analysis of vaccine efficacy, Immunology Letters, 2015, 163, 1, 102

    CrossRef

  2. 2
    Hyun Yang, Dong Seok Kim, 2015,

    CrossRef

  3. 3
    Yasuo Shiohama, Junya Ohtake, Takayuki Ohkuri, Daisuke Noguchi, Yuji Togashi, Hidemitsu Kitamura, Takashi Nishimura, Identification of a meiosis-specific protein, MEIOB, as a novel cancer/testis antigen and its augmented expression in demethylated cancer cells, Immunology Letters, 2014, 158, 1-2, 175

    CrossRef

  4. 4
    Kue Peng Lim, Nicole Ai Leng Chun, Chai Phei Gan, Soo-Hwang Teo, Zainal Ariff Abdul Rahman, Mannil Thomas Abraham, Rosnah Binti Zain, Sathibalan Ponniah, Sok Ching Cheong, Identification of immunogenic MAGED4B peptides for vaccine development in oral cancer immunotherapy, Human Vaccines & Immunotherapeutics, 2014, 10, 11, 3214

    CrossRef

  5. 5
    Junya Ohtake, Takayuki Ohkuri, Yuji Togashi, Hidemitsu Kitamura, Kiyotaka Okuno, Takashi Nishimura, Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccine, Immunology Letters, 2014, 161, 1, 20

    CrossRef

  6. 6
    Katerina Oikonomopoulou, Davor Brinc, Andreas Hadjisavvas, Georgios Christofi, Kyriacos Kyriacou, Eleftherios P. Diamandis, The bifacial role of helminths in cancer: Involvement of immune and non-immune mechanisms, Critical Reviews in Clinical Laboratory Sciences, 2014, 51, 3, 138

    CrossRef

  7. 7
    Lingxiao Zhao, Min Zhang, Hua Cong, Advances in the study of HLA-restricted epitope vaccines, Human vaccines & immunotherapeutics, 2013, 9, 12, 2566

    CrossRef

  8. 8
    V Boncheva, S A Bonney, S E Brooks, M Tangney, G O'Sullivan, A Mirnezami, B-A Guinn, New targets for the immunotherapy of colon cancer—does reactive disease hold the answer?, Cancer Gene Therapy, 2013, 20, 3, 157

    CrossRef

  9. 9
    Akira Yamada, Tetsuro Sasada, Masanori Noguchi, Kyogo Itoh, Next-generation peptide vaccines for advanced cancer, Cancer Science, 2013, 104, 1
  10. 10
    Viswanath Gunda, Alexandria P. Cogdill, Maria J. Bernasconi, Jennifer A. Wargo, Sareh Parangi, Potential role of 5-Aza-2′-deoxycytidine induced MAGE-A4 expression in immunotherapy for anaplastic thyroid cancer, Surgery, 2013, 154, 6, 1456

    CrossRef

  11. 11
    Koji Teramoto, Yasuhiko Ohshio, Takuya Fujita, Jun Hanaoka, Keiichi Kontani, Simultaneous activation of T helper function can augment the potency of dendritic cell-based cancer immunotherapy, Journal of Cancer Research and Clinical Oncology, 2013, 139, 5, 861

    CrossRef

  12. 12
    Neil L Berinstein, Mohan Karkada, Michael A Morse, John J Nemunaitis, Gurkamal Chatta, Howard Kaufman, Kunle Odunsi, Rita Nigam, Leeladhar Sammatur, Lisa D MacDonald, Genevieve M Weir, Marianne M Stanford, Marc Mansour, First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients, Journal of Translational Medicine, 2012, 10, 1, 156

    CrossRef

  13. 13
    Erika Vacchelli, Isabelle Martins, Alexander Eggermont, Wolf Hervé Fridman, Jerome Galon, Catherine Sautès-Fridman, Eric Tartour, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi, Trial watch, OncoImmunology, 2012, 1, 9, 1557

    CrossRef